.svg){kind=small}
Risk mitigation is increasingly important in early medicines development not only to allow early attrition but also to improve the chances of early drug development.Join us at the 23rd AGAH Annual Meeting taking place 13-14 March 2014 in Munich, Germany. Discussions will take into account the impact of nonclinical findings, biopharmaceutics, personalised medicine approaches, updates on safety/tolerability from a clinical pharmacology perspective, as well as early investigation of lack of efficacy.View program and register online
-min.jpg)
.jpg)
Latest news
Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery
September 12, 2023
Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery
Read moreExciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors
September 5, 2023
We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.
Read moreEvents
BioJapan 2023
11-13 October 2023
BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program".
View event
